Voyageur Pharmaceuticals (CVE:VM) Shares Down 11.5% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) was down 11.5% on Saturday . The stock traded as low as C$0.27 and last traded at C$0.27. Approximately 407,425 shares changed hands during trading, an increase of 105% from the average daily volume of 198,342 shares. The stock had previously closed at C$0.31.

Voyageur Pharmaceuticals Stock Performance

The company has a market capitalization of C$40.91 million, a PE ratio of -25.25 and a beta of 0.32. The company has a 50 day moving average of C$0.20 and a two-hundred day moving average of C$0.17. The company has a debt-to-equity ratio of 4.23, a current ratio of 0.10 and a quick ratio of 0.84.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.